Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cytomegalovirus Infection

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 34 articles: HTML format

Single Articles

June 2026
1. LI J, Liu M, Li J, Zhou Y, et al
   Correlates of human Cytomegalovirus Cervical Shedding in Seropositive Women: Implications for Vaccine Development.
   J Infect Dis. 2026 Jun 23:jiag317. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. RIGGS PK, Honerkamp-Smith G, Meneses M, Caballero G, et al
   CMV IgG and EBV Cell-Associated DNA Independently Associate With Veterans Aging Cohort Study (VACS) Index 2.0 Scores in People With HIV on Antiretroviral Therapy.
   J Infect Dis. 2026 Jun 18:jiag310. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. LICHTNER M, Vita S
   CMV and EBV: a dynamic, powerful, and dangerous duo in PLWH.
   J Infect Dis. 2026 Jun 18:jiag311. doi: 10.1093.
   PubMed    
   
   
   
4. MOMKUS J, Harris KM, Edwards JK, Yang YC, et al
   A Pathogen Penalty? Associations Between Persistent Infections and Biological Aging in the US.
   J Infect Dis. 2026;233:e1320-e1329.
   PubMed     Abstract available
   
   
   May 2026
5. SUGIYAMA Y, Koizumi J, Kondo H, Takahashi K, et al
   Postnatal Cytomegalovirus Infection in Preterm Infants
   J Infect Dis. 2026 May 9:jiag259. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2026
6. CHAUHAN L, Ghosh D, Ances B, Tassiopoulos K, et al
   CMV Immune Responses and Cognitive Impairment in People with HIV.
   J Infect Dis. 2026 Apr 28:jiag239. doi: 10.1093.
   PubMed     Abstract available
   
   
   
7. HUGHES BL, MacPherson C, Rouse DJ, Saade GR, et al
   Maternal cytomegalovirus serology results by geographic region in a large multicenter United States study.
   J Infect Dis. 2026 Apr 18:jiag224. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. EVANS C, Chandna J, Mutasa K, Rukobo S, et al
   Neurodevelopment in children exposed to antenatal CMV viraemia in a high HIV prevalence area.
   J Infect Dis. 2026 Apr 9:jiag214. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2026
9. JACOBS TG, Martson AG
   Interpreting ganciclovir plasma concentrations to inform dosing and therapeutic drug monitoring in (preterm) infants with CMV.
   J Infect Dis. 2026 Mar 27:jiag188. doi: 10.1093.
   PubMed    
   
   
   
10. JIHAD T, Chi XS, He Z, Lee K, et al
    Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development.
    J Infect Dis. 2026 Mar 23:jiag170. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2026
11. BOECKH M, Corey L
    Cytomegalovirus and Aging-How Can the Field Move Forward?
    J Infect Dis. 2026 Feb 28:jiag099. doi: 10.1093.
    PubMed    
    
    
    January 2026
12. HAIDAR G
    Beyond Transplantation: Cytomegalovirus Viremia as a Therapeutic Target in Non-Cytomegalovirus Syndromes.
    J Infect Dis. 2026 Jan 14:jiaf648. doi: 10.1093.
    PubMed    
    
    
    December 2025
13. BOECKH M, Xie H, Stevens-Ayers T, Sircy L, et al
    Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes.
    J Infect Dis. 2025 Dec 31:jiaf649. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. FAURE BARDON V, Bouazza N, Peytavin G, Le MP, et al
    Maternal-Fetal Letermovir Exposure in Vivo and PBPK-based: A Rationale for Congenital CMV Therapy.
    J Infect Dis. 2025 Dec 17:jiaf619. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. LINDQUIST-KLEISSLER B, Kfoury P, Kuo K, Elwood C, et al
    Intracellular Ganciclovir Tri-Phosphate Concentrations in Children with Congenital Cytomegalovirus Infection.
    J Infect Dis. 2025 Dec 11:jiaf633. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2025
16. CLARK ES, Garrido G, Levay A, Schrand B, et al
    Vaccination against pathogens targeting cell-derived cryptic antigens.
    J Infect Dis. 2025 Nov 24:jiaf593. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2025
17. ACOSTA EP, Aban I, Ryan KJ, Sanchez PJ, et al
    Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study.
    J Infect Dis. 2025 Oct 10:jiaf528. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
18. LEGG SB, Moylan DC, Kamau N, Latting MP, et al
    Tissue-Resident CD8+ T Cells as Mediators of Protective Immunity in Breast Milk Transmission of Human Cytomegalovirus.
    J Infect Dis. 2025;231:1327-1335.
    PubMed     Abstract available
    
    
    May 2025
19. ALMEIDA S, Goncalves-Pereira MH, Bicalho ACM, Vidigal T, et al
    Association of HLA Class I Repertoire Score with Severity of Human Cytomegalovirus Infection in Transplant Patients.
    J Infect Dis. 2025 May 21:jiaf261. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
20. ARMISTEAD B, Peters MQ, Houck J, Carlson M, et al
    Exposure to HIV is associated with altered composition of maternal microchimeric T cells in infants.
    J Infect Dis. 2024 Oct 22:jiae521. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
21. CHOU S, Winston DJ, Avery RK, Cordonnier C, et al
    Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection.
    J Infect Dis. 2024 Sep 20:jiae469. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
22. NAGELE K, Battig V, Gosert R, Walti CS, et al
    Revealing the unseen: next generation sequencing for early detection of drug-resistant cytomegalovirus variants upon letermovir prophylaxis failure.
    J Infect Dis. 2024 Aug 30:jiae414. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
23. MARCHANT A, Adali S, Alsdurf H, Bol V, et al
    Establishing correlates of maternal-fetal cytomegalovirus transmission-one step closer through predictive modeling.
    J Infect Dis. 2024 Jun 12:jiae281. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. STRIZKI JM, Diamond TL, Teal VL, Gilbert CL, et al
    Cytomegalovirus antiviral resistance among participants in the phase 3 trial of letermovir vs valganciclovir prophylaxis in kidney transplant recipients.
    J Infect Dis. 2024 Jun 10:jiae287. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
25. FIERRO C, Brune D, Shaw M, Schwartz H, et al
    Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1, Randomized, Clinical Trial.
    J Infect Dis. 2024 Mar 13:jiae114. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
26. HU X, Karthigeyan KP, Herbek S, Valencia SM, et al
    Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine.
    J Infect Dis. 2024 Feb 7:jiad593. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
27. VENTURINI C, Colston JM, Charles O, Lankina A, et al
    Persistent low-level variants in a subset of viral genes are highly predictive of poor outcome in immunocompromised patients with cytomegalovirus infection.
    J Infect Dis. 2024 Jan 5:jiae001. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
28. FERNANDEZ-RUIZ M, Garcia-Rios E, Redondo N, Rodriguez-Goncer I, et al
    Post-transplant dynamics and clinical significance of CMV-specific neutralizing antibodies in kidney transplant recipients treated with T-cell-depleting agents.
    J Infect Dis. 2023 Sep 22:jiad411. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. HUANG Y, Tang J, Yu H, Song Q, et al
    Reconsideration of maternal serological testing for predicting congenital CMV infection.
    J Infect Dis. 2023 Sep 21:jiad412. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. SADOWSKA-KLASA A, Leisenring WM, Limaye AP, Boeckh M, et al
    Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation with CMV Disease.
    J Infect Dis. 2023 Sep 8:jiad386. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
31. CHOU S, Alain S, Cervera C, Chemaly RF, et al
    Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
    J Infect Dis. 2023 Jul 28:jiad293. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
32. PARIS R, Apter D, Boppana S, D'Aloia M, et al
    Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls: Results From a Prospective Study.
    J Infect Dis. 2023 Jun 21:jiad182. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2023
33. ALVAREZ-HEREDIA P, Reina-Alfonso I, Dominguez-Del Castillo JJ, Gutierrez-Gonzalez C, et al
    Accelerated T cell immunosenescence in CMV-seropositive individuals after SARS-CoV-2 infection.
    J Infect Dis. 2023 Apr 26:jiad119. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
34. HASTIE E, Moser C, Sun X, Lennox J, et al
    Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy.
    J Infect Dis. 2023 Mar 7:jiad060. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum